Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Convatec Group Plc LSE:CTEC London Ordinary Share GB00BD3VFW73 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  3.30 1.66% 201.70 201.10 201.40 203.00 197.85 197.90 3,305,979 16:35:27
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 1,385.5 127.8 4.2 48.7 4,001

ConvaTec Group PLC Total Voting Rights

02/11/2020 2:30pm

UK Regulatory (RNS & others)


Convatec (LSE:CTEC)
Historical Stock Chart


From Oct 2020 to Apr 2021

Click Here for more Convatec Charts.

TIDMCTEC

RNS Number : 9820D

ConvaTec Group PLC

02 November 2020

ConvaTec Group Plc ("the Company") - Total Voting Rights

Reading, United Kingdom (2 November 2020)

The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. As at 31 October 2020, the Company's issued capital with voting rights consisted of 2,004,347,138 ordinary shares of 10p each. The Company does not hold any shares in Treasury at the date of this disclosure.

The above figure ( 2,004,347,138) can be used by shareholders as the denominator for the calculations by which to determine if they are required to notify their interest in, or a change to, their interest in the Company under the UK Financial Conduct Authority's Disclosure and Transparency Rules.

Enquiries:

Analysts and Investors

Kate Postans, VP Investor Relations & Corporate Communications +44 (0)7826 447807

ir@convatec.com

Media

Buchanan: Charles Ryland/Chris Lane +44 (0)207 466 5000

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our vision, which encompasses our purpose, is: Pioneering trusted medical solutions to improve the lives we touch. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TVRMZMGMDZGGGZM

(END) Dow Jones Newswires

November 02, 2020 09:30 ET (14:30 GMT)

1 Year Convatec Chart

1 Year Convatec Chart

1 Month Convatec Chart

1 Month Convatec Chart
ADVFN Advertorial
Your Recent History
LSE
CTEC
Convatec
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210413 16:41:24